Cargando…
Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
BACKGROUND: Triple-negative breast cancers (TNBCs) lack the estrogen, progesterone, and epidermal growth factor (EGF) receptor-2 (HER2/neu) receptors. Patients with TNBC have typical high grading, more frequent relapses, and exhibit poorer outcomes or prognosis compared with the other subtypes of br...
Autores principales: | Haxho, Fiona, Allison, Stephanie, Alghamdi, Farah, Brodhagen, Lacey, Kuta, Victoria EL, Abdulkhalek, Samar, Neufeld, Ronald J, Szewczuk, Myron R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266271/ https://www.ncbi.nlm.nih.gov/pubmed/25525387 http://dx.doi.org/10.2147/BCTT.S74663 |
Ejemplares similares
-
Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma
por: Abdulkhalek, Samar, et al.
Publicado: (2014) -
Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma
por: Hrynyk, Michael, et al.
Publicado: (2015) -
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
por: O’Shea, Leah K, et al.
Publicado: (2014) -
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis
por: Haxho, Fiona, et al.
Publicado: (2016) -
Oseltamivir phosphate released from injectable Pickering emulsions over an extended term disables human pancreatic cancer cell survival
por: Wood, Kurt, et al.
Publicado: (2018)